Vyome Holdings, Inc (HIND) stock
HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.53−0.05 (-3.16%)
Close on Nov 16, 2026Market cap $10.74MP/E –Yield –
Vyome total assets
Total assets on the balance sheet at the end of each period.
Vyome's total assets was $8.61M at Sep 30, 2026. For fiscal 2025 it was $6.50M, up 370.3% from the year before. Over ten years it grew -7.5% a year on average. The highest annual figure on record is $78.78M in fiscal 2016.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.50M | +370.3% |
| FY2024 | Dec 31, 2024 | $1.38M | -87.0% |
| FY2023 | Dec 31, 2023 | $10.66M | -4.3% |
| FY2022 | Dec 31, 2022 | $11.14M | -78.8% |
| FY2021 | Dec 31, 2021 | $52.53M | +41.7% |
| FY2020 | Dec 31, 2020 | $37.06M | +81.7% |
| FY2019 | Dec 31, 2019 | $20.39M | -32.9% |
| FY2018 | Dec 31, 2018 | $30.39M | -42.8% |
| FY2017 | Dec 31, 2017 | $53.10M | -32.6% |
| FY2016 | Dec 31, 2016 | $78.78M | +454.0% |
| FY2015 | Dec 31, 2015 | $14.22M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $8.61M | +22.2% |
| Q2 FY2026 | Jun 30, 2026 | $9.18M | +1.6% |
| Q1 FY2026 | Mar 31, 2026 | $10.19M | +605.8% |
| Q4 FY2025 | Dec 31, 2025 | $6.50M | +370.3% |
| Q3 FY2025 | Sep 30, 2025 | $7.05M | +451.2% |
| Q2 FY2025 | Jun 30, 2025 | $9.03M | +41.2% |
| Q1 FY2025 | Mar 31, 2025 | $1.44M | -82.5% |
| Q4 FY2024 | Dec 31, 2024 | $1.38M | -87.0% |
| Q3 FY2024 | Sep 30, 2024 | $1.28M | -83.7% |
| Q2 FY2024 | Jun 30, 2024 | $6.39M | -46.1% |
| Q1 FY2024 | Mar 31, 2024 | $8.23M | -49.7% |
| Q4 FY2023 | Dec 31, 2023 | $10.66M | -4.3% |
| Q3 FY2023 | Sep 30, 2023 | $7.83M | -70.4% |
| Q2 FY2023 | Jun 30, 2023 | $11.85M | -70.6% |
| Q1 FY2023 | Mar 31, 2023 | $16.35M | -64.2% |
| Q4 FY2022 | Dec 31, 2022 | $11.14M | -78.8% |
| Q3 FY2022 | Sep 30, 2022 | $26.49M | -70.8% |
| Q2 FY2022 | Jun 30, 2022 | $40.36M | -66.4% |
| Q1 FY2022 | Mar 31, 2022 | $45.62M | +163.1% |
| Q4 FY2021 | Dec 31, 2021 | $52.53M | +41.7% |
| Q3 FY2021 | Sep 30, 2021 | $90.79M | +659.0% |
| Q2 FY2021 | Jun 30, 2021 | $120.01M | +765.1% |
| Q1 FY2021 | Mar 31, 2021 | $17.34M | -9.8% |
| Q4 FY2020 | Dec 31, 2020 | $37.06M | +81.7% |
| Q3 FY2020 | Sep 30, 2020 | $11.96M | -51.5% |
| Q2 FY2020 | Jun 30, 2020 | $13.87M | -27.7% |
| Q1 FY2020 | Mar 31, 2020 | $19.23M | -40.6% |
| Q4 FY2019 | Dec 31, 2019 | $20.39M | -32.9% |
| Q3 FY2019 | Sep 30, 2019 | $24.66M | -33.1% |
| Q2 FY2019 | Jun 30, 2019 | $19.20M | -40.9% |
| Q1 FY2019 | Mar 31, 2019 | $32.37M | -20.1% |
| Q4 FY2018 | Dec 31, 2018 | $30.39M | -42.8% |
| Q3 FY2018 | Sep 30, 2018 | $36.88M | -37.6% |
| Q2 FY2018 | Jun 30, 2018 | $32.47M | -50.0% |
| Q1 FY2018 | Mar 31, 2018 | $40.51M | -42.6% |
| Q4 FY2017 | Dec 31, 2017 | $53.10M | -32.6% |
| Q3 FY2017 | Sep 30, 2017 | $59.08M | – |
| Q2 FY2017 | Jun 30, 2017 | $64.98M | – |
| Q1 FY2017 | Mar 31, 2017 | $70.59M | – |
| Q4 FY2016 | Dec 31, 2016 | $78.78M | – |
See a number that looks wrong?